SCHEMBL21497380

SCHEMBL21497380

CC(C)(C)c1cnc2ccc(CC(C)(C)c3ccc4ncccc4c3)cc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNRHR P30968 1/20 0.41
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TP53 P04637 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
CASP1 P29466 1/20 0.40
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
CHKA P35790 1/20 0.39
MET P08581 6/20 0.38
PDE10A Q9Y233 1/20 0.38
HDAC3 O15379 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515395 0.89 GNRHR (0.35) GNRHRALDH1A1KDM4ETP53HSP90AA1
SCHEMBL23190476 0.87 ALDH1A1 (0.40) GNRHRALDH1A1KDM4ETP53HSP90AA1
SCHEMBL20932780 0.86 ALDH1A1 (0.39) GNRHRALDH1A1KDM4ETP53HSP90AA1
SCHEMBL25054101 0.85 ALDH1A1 (0.40) GNRHRALDH1A1KDM4ETP53HSP90AA1
SCHEMBL28091363 0.80 ALDH1A1 (0.53) ALDH1A1KDM4ETP53HSP90AA1HSP90AB1
SCHEMBL24657653 0.79 GNRHR (0.39) GNRHRALDH1A1KDM4ETP53HSP90AA1
SCHEMBL264293 0.78 ALDH1A1 (0.58) ALDH1A1KDM4ETP53HSP90AA1HSP90AB1
SCHEMBL26315520 0.77 ALDH1A1 (0.39) GNRHRALDH1A1KDM4ETP53HSP90AA1
SCHEMBL19341334 0.77 KCNH2 (0.40) ALDH1A1KDM4EMAPTHTTSMN1; SMN2
SCHEMBL9969439 0.76 ALDH1A1 (0.53) ALDH1A1KDM4ETP53HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450286-B2 Compounds and compositions for inhibition of FASN FORMA THERAPEUTICS, INC. (US) 2019-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450286-B2 Compounds and compositions for inhibition of FASN FASN, FABP1, SCD GNRHR 4154/4885ALDH1A1 1393/4885KDM4E 4280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.